Consider 3M™ Veraflo™ Therapy on Day 1.

Read the article to view all the data and results.

  • 3M™ Bair Hugger™ 1100 Upper Body Graphic

  • Data suggests that initiating negative pressure wound therapy with instillation and dwell (NPWTi-d) with Veraflo Therapy within 1 day of NPWT (as opposed to 2-7 days of NPWT application) helped deliver a combination of positive clinical and health economic outcomes, including1*:

    • 4.4 days shorter average duration of NPWT therapy (7.0 vs 11.4; p < 0.0001)
    • Nearly 3 days shorter average length of stay (13.4 vs 16.3; p < 0.0001)
    • Fewer wound-related readmissions at 30 days (6 vs 16; p = 0.0293) and 60 days (10 vs 24; p = 0.0130)
    • $10,877 lower mean cost of index admission ($34,161 vs $45,038; p < 0.0001)
    • Fewer OR visits during NPWT (1.7 vs 2.9; p < 0.0001)
    Read full article

  • Potential to save days and dollars

    Early initiation (within 1 day) of Veraflo Therapy helped improve patient outcomes and reduce care costs versus waiting 2 to 7 days.1*


  • Cleanse wounds, manage bioburden

    Infection may start much sooner than we can easily detect. From clean-"looking" yet potentially contaminated wounds to wounds with heavy bioburden and infection, Veraflo Therapy can be used to help manage a wide range of wound types and characteristics.


  • Make NPWTi-d easier on everyone

    Recent software and dressing kit upgrades make things easier for everyone involved—surgeons, nurses, and patients. Your 3M account team is always at the ready to train surgeons and nurses in the use of Verao Therapy on Day 1.

Get started with Veraflo Therapy.

  • All fields are required unless indicated optional

  • Check all that apply.

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit

NOTE: Specifc indications, contraindications, warnings, precautions, and safety information exist for these products and therapies. Please consult a clinician and product Instructions for Use prior to application. Rx only.


*A retrospective analysis was conducted utilizing a national, all-payer hospital database and included patients who received NPWTi-d (3M™ Veraflo™ Therapy) as an inpatient visit in 2019. A matched cohort of 514 patients who received either early (within 1 day of NPWT application) or late (within 2-7 days of NPWT application) NPWTi-d initiation was created using propensity scoring.


1. Collinsworth AW, Griffn LP. The effect of timing of instillation therapy on outcomes and costs for patients receiving negative pressure wound therapy. Wounds. 2022;34(11):269-275.

The brands listed above are trademarks of 3M.